CRSP News and Press, CRISPR Therapeutics AG

2024-06-27 15:21:32 ET Summary bluebird bio, Inc. stock plummeted by 73% amid financial struggles and operational hurdles post FDA approval of their gene therapy Lyfgenia. The company faces intense competition from CRISPR Therapeutics' Casgevy, which benefits from stronger resourc...

2024-06-25 08:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Gene-editing stocks has been gaining substantial attention, as the industry holds the potential to revolutionize medicine. From curing genetic disorders to enhancing agricultural productivity, ...

2024-06-24 10:54:44 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Chasing the next trend thing after AI is easier said than done. It is also a pretty risky strategy. Companies that have ambitious goals also need a good deal of cash to achieve growth in their ...

2024-06-20 17:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-06-17 13:20:51 ET Summary Vertex Pharmaceuticals Incorporated is a $120bn market cap pharma giant with a successful CF franchise, growing revenues from $1bn in 2015 to $9.9bn in 2023. Vertex gained approval for its first non-CF drug, Casgevy, utilizing CRISPR technology to tr...

2024-06-12 13:44:44 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Because it’s tied to one of the six leading causes of “finality,” stress represents a silent public health crisis. And few things cause heightened stress than dealing w...

2024-06-11 12:32:06 ET CRISPR Therapeutics AG (CRSP) Company Conference Call June 11, 2024 9:20 am ET Company Participants Sam Kulkarni - Chief Executive Officer Conference Call Participants Salveen Richter - Goldman Sachs Presentation Salveen R...

2024-06-10 10:27:19 ET Summary CRISPR Therapeutics’ new gene-editing protocol gives it a legitimate claim to be the future of medicine. That powered the stock back in 2020-21. But at some point, it’ll take revenues and profits, not futurism to justify stock owner...

2024-06-09 06:20:00 ET Cathie Wood is known for two things: picking out innovators that will go on to score a win over the long run, and getting in on these stocks at a great price. The founder and chief executive officer of Ark Invest doesn't mind going against the crowd and choosing compa...

2024-06-07 18:26:03 ET Summary The "Undercovered" Dozen highlights twelve ideas from the previous month on stocks with limited coverage. Biotechs CRISPR Therapeutics, Voyager Therapeutics, and Alnylam Pharmaceuticals are covered along with Enovix, Uranium Royalty, Clover Health, a...